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Advanced stage 
at diagnosis 
Metastasis 
The chemoresistance to placlitaxel promotes the epithelial-mesenchymal 
transition in the four main epithelial ovarian tumor types by the upregulation 
of the transcription factors that repress E-cadherin. 
Chemoresistance  
to paclitaxel 
EMT 
↑ Snail, Slug, Twist1, 
Zeb1 and Zeb2  
↓ E-cadherin 
• Establishment of paclitaxel resistance and chemosensitivity assay: IC50 
• Proliferation: MTT assay 
• Anchorage-independent growth: Soft agar assay 
• Invasion:  Boyden chamber assay 
• Migration: Wound-healing assay 
• Immunofluorescence 
• Western Blot 
• Statistical analysis 
Expected results 
• Analyze paclitaxel resistant ovarian carcinoma cells: 
phenotype, migration, proliferation, gene expression. 
• Determine if there is a relation between the activation of 
the transcription factors and the acquisition of paclitaxel 
chemoresistance.  
• Compare the results of the different tumor types. 
• Human cell lines 
Serous ovarian adenocarcinoma from ascites (OV17R) 
Mucinous ovarian carcinoma (COV644) 
Endometrioid ovarian carcinoma (COV362) 
Clear cell ovarian carcinoma(ES-2) 
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Fig. 2  Morphologic changes. Spindle-cell shaped 
cells with loss of polarity (red), intercellular 
separation (green), and pseudopodia (white). x20 
magnifications. Modified from Yang AD et al.  
Fig. 3  Proliferation assay. Modified from 
Yang AD et al.  
Fig. 5 Wound healing assay. Modified from 
Yang YC et al. 
Fig. 6  Immunofluorescence staining. Scale 
bars, 100 μm. Modified from Evdokimova et 
al. 
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Fig. 7 Western Blot.  
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Fig. 4 Soft Agar assay.  
Modified from Dallas et al.  
↓ IC50 ↑ IC50 
 ↑ Cell number  ↓ Cell number 
 ↓ Colonies  ↑ Colonies 
 ↓ Cell invasion  ↑ Cell invasion 
 ↓ Cell migration  ↑ Cell migration 
 ↑E-cadherin, ↓N-cadherin, ↓Vimentin  ↓E-cadherin, ↑N-cadherin, ↑Vimentin 
 ↓ Gene expression  ↑ Gene expression 
A better understanding of the mechanisms that underlie the 
chemoresistance by which tumor cells survive treatment could 
lead to the identification of novel therapeutic targets and 
development of an appropriate therapy for certain cancers, like 
ovarian carcinoma, for which the early detection is still a barrier. 
Fig. 1 Epithelial-mesenchymal transition process in cancer: from a 
primary tumor epithelial cell to a motile mesenchymal cell. Meng F et al. 
